In immune cells, PD-L1 expression was seen in 8.2% of 1036 tumors with highest frequencies in papillary RCCs (13.9%), followed by clear cell RCC (7.7%), and oncocytomas (5.8%, Supplementary Table 1). Here, CD274 is linked to oncocytic adenoma.